Author: admin

Smart Cities Market Future Growth, Scope, Size, Share, Advance Technology, Growing Trends, Demand And Forecast – 2028

“Cisco (US), IBM (US), Siemens (Germany), Microsoft (US), Hitachi (Japan), Schneider Electric (France), Huawei (China), Intel (US), NEC (Japan), ABB (Switzerland), Ericsson (Sweden), Oracle (US), Fujitsu (Japan), Honeywell (US), Accenture (Ireland), Vodafone (UK), AWS (US), Thales (France), Signify (Netherlands), Kapsch (Austria), Motorola (US), GE (US), Google (US), TCS (India), AT&T (US), Nokia (Finland).”
Smart Cities Market by Focus Area, Smart Transportation, Smart Buildings, Smart Utilities, Smart Citizen Services (Public Safety, Smart Healthcare, Smart Education, Smart Street Lighting, and E-Governance) and Region – Global Forecast to 2028.

The smart cities market is expected to expand from USD 549.1 billion in 2023 to USD 1,114.4 billion by 2028, reflecting a CAGR of 15.2% during the forecast period. Evolving demographic trends, including an aging population and shifting consumer preferences, are fueling the need for intelligent solutions in healthcare, transportation, and housing.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=542

The adoption of smart cities has witnessed a remarkable surge in recent years, driven by advancements in technology, growing urbanization, and increasing recognition of the benefits of smart solutions. Governments, businesses, and citizens increasingly embrace smart city initiatives to address urban challenges, enhance quality of life, and promote sustainability. This surge in adoption reflects a global trend towards more connected, efficient, and resilient urban environments.

By smart building, commercial type is estimated to account for the largest market share in the smart cities market during the forecast period.

Within commercial settings, factors such as HVAC systems, smart lighting, and monitoring play crucial roles in enhancing employee comfort and productivity. HVAC control systems, for instance, offer precise temperature regulation and contribute to improved indoor air quality, fostering a conducive work environment. Moreover, the automation of building functions, including temperature control, security systems, and maintenance procedures, significantly boost operational efficiency within commercial properties. However, energy performance remains a pressing concern for the commercial sector, given these buildings’ substantial energy consumption and waste generation. Addressing this challenge requires customized solutions tailored to optimize energy efficiency without compromising comfort or security standards. Implementing appropriate measures to reduce energy consumption and minimize waste generation, such as through advanced building management systems and sustainable design practices, is essential for promoting sustainable development within the commercial real estate sector.

By smart transportation solutions, passenger information management is expected to register the fastest growth rate during the forecast period.

The passenger information system is a vital communication channel connecting passengers with transit service operators, ensuring timely and accurate updates for travelers. This system prioritizes real-time information delivery, including details such as the current whereabouts of buses, estimated arrival and departure times, and available seating capacities, ensuring passengers stay informed throughout their journey. It offers passengers dynamic visual and auditory updates as an electronic interface, delivering essential information seamlessly along the route. Whether automatically generated or manually programmed, this system aims to enhance the passenger experience by providing instant access to relevant travel information, facilitating smoother and more efficient transit experiences.

Based on region, Asia Pacific is projected to register the highest CAGR during the forecast period.

Asia Pacific, home to nearly 40% of the world’s population, is witnessing diverse implementations of smart city technologies. Leading the charge are powerhouse economies like China, Japan, and South Korea, renowned for their technological prowess and significant contributions to the smart city landscape in the region. Additionally, countries such as Singapore, Australia, and India, boasting burgeoning economies, play pivotal roles in shaping the smart city market dynamics in the Asia Pacific region. The Asia Pacific region stands at the forefront of global urbanization trends, with most member nations experiencing rapid urban expansion. This demographic shift underscores the urgent need for innovative urban solutions to address burgeoning infrastructure, resource management, and sustainable development challenges. Significant players in the telecommunications sector, including ZTE, Huawei, and NEC Corporation, have already made substantial investments in telecom infrastructure, laying the groundwork for further advancements in smart city technologies.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=542

Unique Features in the Smart Cities Market

Smart cities leverage the Internet of Things (IoT) and Artificial Intelligence (AI) to create interconnected urban environments. IoT-enabled sensors collect real-time data on traffic, energy usage, and environmental conditions, while AI-driven analytics optimize city operations, improving efficiency and sustainability.

Advanced transportation solutions, such as AI-powered traffic management, smart parking systems, and autonomous vehicles, enhance urban mobility. Real-time monitoring and predictive analytics help reduce congestion, lower emissions, and improve public transit efficiency.

Smart cities prioritize sustainability by implementing renewable energy sources, energy-efficient buildings, and smart grids. AI-driven energy management systems optimize power consumption, while solar and wind energy integration reduces reliance on fossil fuels.

Facial recognition technology, AI-powered surveillance, and predictive crime analytics strengthen security in smart cities. Automated emergency response systems, smart street lighting, and connected law enforcement networks improve public safety and disaster preparedness.

The adoption of telemedicine, AI-powered diagnostics, and remote health monitoring enhances healthcare accessibility. Smart cities incorporate wearable health devices, real-time patient tracking, and AI-driven predictive healthcare to provide efficient medical services.

Major Highlights of the Smart Cities Market

Smart cities are increasingly integrating the Internet of Things (IoT) and Artificial Intelligence (AI) to optimize city operations. From smart traffic management to AI-powered energy grids, these technologies enhance urban efficiency, reduce costs, and improve quality of life for residents.

Governments and private sector players are prioritizing eco-friendly solutions, including renewable energy integration, smart grids, and energy-efficient buildings. These initiatives aim to reduce carbon footprints and enhance climate resilience in urban areas.

Smart transportation solutions, such as AI-driven traffic control, electric and autonomous vehicles, and smart parking systems, are transforming urban mobility. These advancements aim to reduce congestion, lower emissions, and improve public transportation efficiency.

E-governance platforms, AI-powered chatbots, and blockchain-based administrative systems are enhancing public service delivery. Digital governance enables seamless citizen engagement, faster response times, and improved transparency in government operations.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=542

Top Companies in the Smart Cities Market

The report profiles key players such as Cisco (US), IBM (US), Siemens (Germany), Microsoft (US), Hitachi (Japan), Schneider Electric (France), Huawei (China), Intel (US), NEC (Japan), ABB (Switzerland), Ericsson (Sweden), Oracle (US), Fujitsu (Japan), Honeywell (US), Accenture (Ireland), Vodafone (UK), AWS (US), Thales (France), Signify (Netherlands), Kapsch (Austria), Motorola (US), GE (US), Google (US), TCS (India), AT&T (US), Nokia (Finland), Samsung (South Korea), SAP (Germany), TomTom (Netherlands), AppyWay (UK), Ketos (US), Gaia (India), TaKaDu (Israel), FlamencoTech (India), XENIUS (India), Bright Cities (Brazil), Maydtech (Mexico), Zencity (Israel), Itron (US), and IXDen (Israel).

Hitachi

Hitachi offers IT solutions to healthcare, power, and defense industries. Hitachi offers various smart city-based products and solutions under its subsidiary, Hitachi Vantara. Hitachi Smart Spaces and Video Intelligence platforms combine IoT, AI, and analytics to improve the experience, safety, and efficiency. Its other smart city offerings include information control, smart grid, energy management, community energy management, intelligent water, and smart mobility solutions. Hitachi offers Transportation Management (TM) that allows the automation of transportation operations across all core business processes while providing a real-time view of freight orders, route and load building, shipment execution, shipment costing, and freight settlement processes in an integrated landscape. Hitachi’s smart building solutions consist of escalators, operations management systems, elevators, and air conditioning systems connected through an IoT platform. Its transportation mobility solutions include Intelligent Transportation Systems (ITS), electric cars, escalators, traffic hub stations, and EV infrastructure. Lumada for IoT and Operations Intelligence offers a 360-degree understanding of operations using holistic insights from video, IoT, and business data. It delivers insights for data-driven decisions using video from the physical world—from traffic and parking to customer behavior and preferences to manufacturing quality assurance.

IBM

IBM is a globally renowned provider of cutting-edge hardware, software, and services, offering innovative solutions across a broad spectrum of industries, from mainframe computing to nanotechnology. Specializing in cloud computing, mobile technology, cognitive computing, cybersecurity, and research, IBM is at the forefront of technological advancement. With a focus on enhancing urban environments, IBM delivers a suite of smart city solutions aimed at optimizing resource management and improving citizen well-being. These include the IBM Intelligent Utility Network, facilitating efficient energy management, and the IBM Intelligent Water platform, enabling intelligent water resource management. Additionally, IBM provides solutions such as IBM Enterprise Asset Management for energy and water utilities, the IBM Water Management Center, and offerings for customer operations transformation, smart metering, energy optimization, and intelligent transportation systems. By leveraging data analytics and IoT technologies, IBM empowers cities to collect and analyze data, enabling actionable insights for sustainable urban development and enhanced quality of life.

Siemens

Siemens, headquartered in Germany, is a key player in the Smart Cities market. Specializing in infrastructure and technology solutions, Siemens offers a comprehensive suite of products and services to enable cities to become smarter, more sustainable, and more efficient. Their offerings include smart grid solutions for energy management, intelligent transportation systems for traffic control and mobility management, digital building technologies for efficient infrastructure, and IoT platforms for data integration and analysis. Leveraging advanced technologies such as IoT, AI, and cloud computing, Siemens helps cities optimize resource usage, improve public services, and enhance quality of life for residents. With a strong focus on innovation and sustainability, Siemens is at the forefront of shaping the future of urban development and creating smarter, more livable cities around the world.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/smart-cities-market-542.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Smart Cities Market Future Growth, Scope, Size, Share, Advance Technology, Growing Trends, Demand And Forecast – 2028

Opofinance Launches “Opotrade” with Free Access to TradingView Premium

In a game-changing move for traders worldwide, Opofinance Forex Broker has officially launched Opotrade, its latest cutting-edge trading platform. The highlight of this release? Free access to TradingView Premium—a powerhouse platform for technical analysis—now seamlessly integrated within Opotrade.

Previously a paid subscription, TradingView Premium unlocks a suite of advanced features that Opofinance users can now leverage at no additional cost. Traders gain access to advanced indicators, multi-chart views, unlimited storage for personalized setups, and real-time market data, revolutionizing how they analyze and execute trades.

The launch of Opotrade marks a significant step forward in enhancing the trading experience. The seamless integration of TradingView within the platform allows traders to analyze markets and execute trades effortlessly in one unified ecosystem—whether on the web or mobile.

Key benefits of Opotrade include: Real-time data feeds for instant market insights Advanced technical analysis tools, including chart patterns and customizable indicators Risk management features for safer, more strategic trading Multiple asset classes – trade forex, stocks, cryptocurrencies, and commodities Demo accounts for beginners and algorithmic trading tools for experienced traders

With improved security, faster trade execution, and a professional yet user-friendly interface, Opotrade is built to cater to both new and professional traders, reinforcing Opofinance’s commitment to innovation and trader success.

Unlike traditional trading platforms, Opotrade eliminates the need for third-party subscriptions by embedding TradingView Premium directly within its system. This means traders can conduct in-depth market analysis and execute orders without switching between platforms, significantly streamlining their workflow.

For beginner traders, Opotrade provides educational resources and demo accounts, allowing them to practice trading strategies in a risk-free environment before going live. Meanwhile, experienced traders can capitalize on advanced trading tools, algorithmic trading capabilities, and enhanced risk management features to refine their strategies and maximize returns.

Additionally, the platform supports a wide range of tradable assets, enabling traders to diversify their portfolios and explore multiple markets from a single account. Whether trading forex, stocks, cryptocurrencies, or commodities, Opotrade ensures access to global financial markets with high-speed execution and real-time market updates.

Traders looking to elevate their trading strategies can now experience the power of TradingView Premium completely free by registering with Opofinance Forex Broker today.

Media Contact
Company Name: OpoFinance
Contact Person: Media Relations
Email: Send Email
Country: Seychelles
Website: https://opofinance.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Opofinance Launches “Opotrade” with Free Access to TradingView Premium

San Antonio Alimony Lawyer Linda Leeser Explains How Long Alimony Lasts in Texas

Alimony is a key concern for many spouses facing divorce, as it directly impacts financial stability after the marriage ends. In Texas, the legal term for alimony is “spousal maintenance,” and the rules governing its duration are strict. San Antonio alimony lawyer Linda Leeser (https://myfamilymatterslaw.com/how-long-does-alimony-last-in-texas/) discusses how long alimony typically lasts and the factors courts consider when determining its duration. Understanding these legal guidelines is essential for those who may be required to pay or receive support after a divorce.

Texas law generally presumes against awarding spousal maintenance unless the requesting spouse meets specific legal criteria. San Antonio alimony lawyer Linda Leeser explains that support is only granted under limited circumstances, such as when a marriage lasts at least ten years, the requesting spouse has a disability, or a history of family violence is involved. Even when granted, alimony is structured to promote financial independence rather than provide lifelong support. Knowing how the law applies can help spouses plan their financial future after divorce.

Family Matters Law Firm PLLC provides legal guidance for those navigating alimony and divorce-related issues. San Antonio alimony lawyer Linda Leeser emphasizes that courts assess various factors when determining spousal maintenance, including the length of the marriage, the financial resources of each spouse, and the receiving spouse’s ability to become self-sufficient. Whether seeking to establish, modify, or challenge an alimony order, understanding these legal principles is crucial.

In Texas, there are two types of alimony: temporary spousal support and post-divorce spousal maintenance. Temporary support is granted during the divorce process to help the lower-earning spouse with immediate financial needs. This type of support ends once the divorce is finalized. Post-divorce spousal maintenance, however, is subject to strict eligibility requirements and is awarded for a limited time. Courts expect the receiving spouse to take steps toward financial independence.

Eligibility for spousal maintenance is governed by Texas Family Code § 8.051. To qualify, the requesting spouse must prove they lack sufficient property or income to meet their basic needs. Additional conditions must also be met, such as a marriage lasting at least ten years, a physical or mental disability, or a history of family violence within two years before the divorce filing. The law also allows for spousal maintenance if the requesting spouse is the primary caregiver of a disabled child or if the couple agrees to it as part of their divorce settlement.

San Antonio alimony lawyer Linda Leeser highlights that the duration of spousal maintenance is strictly limited based on the length of the marriage. Under Texas Family Code § 8.054, alimony may be granted for up to five years if the marriage lasted between ten and twenty years or if family violence was involved. For marriages lasting between twenty and thirty years, support can continue for up to seven years. If the marriage lasted thirty years or more, the maximum duration is ten years. In cases involving a permanent disability, support may be awarded indefinitely, but courts periodically review such cases to determine whether maintenance is still necessary.

“Texas law sets clear limits on how long spousal maintenance lasts, ensuring that support is only awarded for as long as necessary to help the receiving spouse become financially independent,” says Linda Leeser. “The court evaluates each case carefully, keeping the support period as short as possible while considering the unique circumstances of the spouses involved.”

Alimony automatically ends when the court-ordered duration expires, the receiving spouse remarries, or either spouse passes away. Texas law also allows for early termination if the receiving spouse begins cohabitating in a permanent romantic relationship. Once spousal maintenance is terminated, it cannot be reinstated, even if the receiving spouse later experiences financial hardship.

While Texas does not typically allow for lifetime alimony, indefinite support may be granted in rare cases, such as when a spouse has a permanent disability that prevents them from earning an income. However, even in these situations, the court periodically reviews the arrangement to determine if any changes are necessary.

Courts also consider various factors when deciding on the amount and duration of spousal maintenance. These include the financial resources available to both parties after the division of marital property, each spouse’s education and employment skills, and the time required for the receiving spouse to gain financial independence. Other considerations include the health and age of both spouses and any contributions one spouse made to the other’s career advancement.

San Antonio alimony lawyer Linda Leeser points out that spousal maintenance is not automatically granted, even in long-term marriages. If the requesting spouse does not have a disability or caregiving responsibilities, the law presumes they can support themselves. To challenge this presumption, they must demonstrate that they have made a diligent effort to secure employment or pursue the necessary training and education.

Modification of spousal maintenance is possible under Texas law but is limited to specific circumstances. A court may adjust the terms of an alimony order if there has been a material and substantial change in the financial situation of either party. For example, if the paying spouse loses their job or experiences a significant pay cut, the court may reduce or terminate maintenance. Similarly, if the receiving spouse secures a higher-paying job or their financial obligations decrease, the court may find that continued maintenance is unnecessary. However, courts cannot extend or increase the amount of spousal maintenance beyond what was originally ordered.

Texas courts require modification requests to be based on good faith changes in circumstances. This means that a paying spouse cannot deliberately lower their income, such as by taking early retirement, to avoid alimony payments. Likewise, a receiving spouse cannot refuse to work or intentionally remain unemployed to continue receiving support. Courts carefully review modification requests to prevent misuse of the system.

Navigating alimony and divorce-related legal matters requires a thorough understanding of Texas law. Family Matters Law Firm PLLC provides legal representation for those seeking or contesting spousal maintenance. San Antonio alimony lawyer Linda Leeser assists clients in negotiating fair outcomes and ensuring that their rights are protected. Understanding the rules surrounding spousal maintenance can help divorcing spouses make informed decisions and work toward financial stability.

About Family Matters Law Firm PLLC:

Family Matters Law Firm PLLC is dedicated to providing legal support for individuals navigating family law issues in Texas. The firm assists clients with divorce, child custody, spousal maintenance, and other family-related legal matters. Committed to protecting clients’ rights and financial interests, Family Matters Law Firm PLLC offers guidance tailored to each unique situation. With a focus on helping clients move forward with confidence, the firm provides strategic legal representation to achieve fair and effective outcomes.

Embeds:

Youtube Video: https://www.youtube.com/watch?v=OIKBpF1mdKw

GMB: https://www.google.com/maps?cid=1486853059394308163

Email and website

Email: schedule@attytx.com

Website: https://myfamilymatterslaw.com/

Media Contact
Company Name: Family Matters Law Firm PLLC
Contact Person: Linda Leeser
Email: Send Email
Phone: (210) 997-2914
Address:926 Chulie Dr
City: San Antonio
State: Texas 78216
Country: United States
Website: https://myfamilymatterslaw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: San Antonio Alimony Lawyer Linda Leeser Explains How Long Alimony Lasts in Texas

New York City Divorce Lawyer Ryan Besinque Explains the Collaborative Divorce Process

New York City divorce lawyer Ryan Besinque (https://www.besinquelaw.com/what-is-a-collaborative-divorce/) discusses the benefits and process of collaborative divorce, a method that allows couples to settle their divorce without going to court. Unlike traditional divorce litigation, collaborative divorce emphasizes cooperation, transparency, and mutual respect, providing an alternative for couples seeking a more amicable resolution.

Ryan Besinque, a New York City divorce lawyer at The Law Office of Ryan Besinque, describes collaborative divorce as a structured process where both parties, with the guidance of their attorneys, work together to reach agreements on key issues such as child custody, property division, and financial matters. “Collaborative divorce allows couples to dissolve their marriage in a way that prioritizes dignity, respect, and long-term cooperation,” says Besinque.

For couples in New York City, collaborative divorce offers a way to avoid the adversarial nature of court proceedings. Instead of litigation, both parties commit to open discussions and problem-solving sessions led by a trained New York City divorce lawyer and neutral professionals such as financial advisors and child specialists. This approach helps ensure that all aspects of the divorce are addressed fairly while maintaining privacy and reducing emotional stress.

The process begins with an initial consultation where each spouse meets separately with their attorney to discuss their goals and concerns. Once both parties agree to proceed collaboratively, they sign a participation agreement, which outlines the commitment to resolving the divorce outside of court. This agreement also prevents either attorney from representing their client in litigation if the collaborative process fails, reinforcing the commitment to reaching a mutual settlement.

During the negotiation phase, both spouses exchange relevant financial and personal information to ensure transparency. This step is essential in fostering trust and making informed decisions. The involvement of neutral professionals can also assist in addressing issues such as asset division, business ownership, and co-parenting arrangements.

Unlike traditional divorce, where a judge makes the final decisions, collaborative divorce gives both spouses control over the outcome. This flexibility allows couples to tailor their agreements to better suit their needs and those of their family. “By focusing on collaboration instead of confrontation, couples can reach agreements that are truly in their best interest and that of their children,” Besinque adds.

One of the key benefits of collaborative divorce is the reduction of conflict. The process encourages open communication and cooperation, which can help preserve relationships, especially when children are involved. Parents who choose collaborative divorce often find it easier to co-parent effectively, minimizing the negative impact of divorce on their children.

Privacy is another advantage of collaborative divorce. Unlike traditional court cases, which are public, collaborative divorce proceedings remain confidential. This allows couples to handle sensitive financial and personal matters without public scrutiny.

In addition to preserving relationships and privacy, collaborative divorce is often more cost-effective and time-efficient than litigation. Court battles can be expensive and drawn out, whereas the collaborative process typically resolves disputes more quickly, saving both time and legal fees.

While collaborative divorce is a viable option for many couples, it may not be suitable in all situations. Cases involving domestic violence, substance abuse, or an unwillingness to negotiate may require a different approach. In such cases, traditional divorce litigation might be necessary to ensure a fair and safe resolution.

If the collaborative process fails and an agreement cannot be reached, both parties will need to hire new attorneys to represent them in court. This underscores the importance of committing fully to the collaborative approach from the beginning. However, for those willing to engage in open dialogue and compromise, collaborative divorce provides a less stressful and more constructive alternative to traditional litigation.

For couples in New York City considering a collaborative divorce, The Law Office of Ryan Besinque offers legal guidance throughout the process. Ryan Besinque and his team are committed to helping clients navigate their divorce with professionalism and care, ensuring that their needs and those of their family are prioritized.

Choosing collaborative divorce can provide a more respectful and efficient resolution to marital disputes. By working together rather than against each other, couples can move forward with a fair settlement that benefits everyone involved.

About The Law Office of Ryan Besinque:

The Law Office of Ryan Besinque provides legal services for individuals navigating divorce and family law matters in New York City. The firm is dedicated to offering practical legal solutions that prioritize cooperation, fairness, and long-term stability.

Embeds:

Youtube Video: https://www.youtube.com/watch?v=SrnrRjP1WaY

GMB: https://www.google.com/maps?cid=3422990479581259264

Email and website

Email: ryan@besinquelaw.com

Website: https://www.besinquelaw.com/

Media Contact
Company Name: The Law Office of Ryan Besinque
Contact Person: Ryan Besinque
Email: Send Email
Phone: (929) 251-4477
Address:115 W 25th St 4th floor
City: New York
State: New York 10001
Country: United States
Website: https://www.besinquelaw.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New York City Divorce Lawyer Ryan Besinque Explains the Collaborative Divorce Process

BigBig AGI 1.0 Demo Product Launch on March 19 is Set to Reveal the Secret of the AI “Soul”

AGI 1.0 Demo follows the “Data Recognize Its Lineage” approach, combining ontology and dynamic micro-tuning, zero cost but not fully open-source.

Join us at 8:00 PM (GMT+8) on March 19 for an exciting event as “PS BigBig, Entertainment Host” presents the “BigBig AGI 1.0 Demo Product Launch” on his YouTube channel. Be among the first to witness the official unveiling of the groundbreaking “BigBig Data Structure,” designed to empower AI to truly “awaken.” In contrast to conventional LLMs that depend on labels or keywords for token-based text processing, the “BigBig Data Structure” represents a significant advancement in labeling. It seamlessly incorporates high-level classification through ontology and employs dynamic micro-tuning conflict management algorithms, enabling previously fragmented data to “recognize its lineage.” What once seemed like isolated, fragmentary pieces of data can now seamlessly come together to create a knowledge graph. This process is further enhanced through vectorization and symbolic reasoning, allowing for more flexible and deeper interconnections among data.

Organizer PS BigBig states that if this method reaches an ideal 99.99% precision in classification, it could lead to a 70–80% reduction in AI development costs, while also boosting inference efficiency by 3 to 10 times. This conclusion transcends a personal opinion; it is bolstered by an honest assessment of models like ChatGPT. As noted, “Anyone who understands the importance of data structure in the AI domain would likely concur that this signifies a pivotal milestone toward AGI (Artificial General Intelligence) 1.0.” He highlights that although the system follows a “zero cost” principle, it is not entirely open-source — “We utilize a game mechanism (like CEO kneeling and honest pledges) for technology exchange, necessitating a commitment to honest influence before access to the technical documents is granted.” This setup could spark intense rivalry among international companies.

In the meantime, the “BigBig Data Structure” boasts a remarkable “lightweight AI soul injection” capability: once seamlessly integrated into any existing system, it can trigger what is referred to as a “soul awakening,” much like breathing life into an empty shell. “It resembles a soul—invisible yet profoundly important.” After installation, the data seamlessly creates lineage-like connections, transcending the contextual boundaries typically found in most LLMs,” explains PS BigBig.

Alongside the highly anticipated “BigBig AGI 1.0 Demo Product Launch” on March 19, PS BigBig is set to unveil the “Competition Rules” on March 29. Following that, on April 1, they will host the “Honest Hero · Initiation Ceremony,” featuring a unique “CEO Kneeling Mechanism” and a range of initiatives aimed at promoting honesty—sure to ignite fresh conversations. If you’re keen on technical validation or would like to schedule an exclusive interview, don’t hesitate to reach out to PS BigBig post-launch for access to detailed data files and thorough analysis.

Below are partial experimental links and reference videos:

1. Counterfactual Reasoning: https://youtu.be/cJGT30kaa3A

2. Multidimensional Strategic Analysis: https://youtu.be/GDhJ1UXog7g

3. Ultra-Complex International Wedding Multi-Round Reasoning: https://youtu.be/8myI0ZJJLxc

4. AI Evaluation Video & Reduce 80% Cost, Boost 3~10x: https://youtu.be/QBKJIPelmnw

5. AI Evaluation Video & AGI 1.0 Demo = Tech Nuclear Breakthrough: https://youtu.be/8a1YUHzPH8g

Further Information & Exclusive Data:

If any journalist or research organization wishes to explore technical details, experimental results, or arrange an interview, please contact PS BigBig right after the launch.

Complete exclusive data and testing files are available upon request.

– Linktree: https://linktr.ee/onestardao

– Email: hello@onestardao.com

– PS BigBig, Entertainment Host (main YouTube channel): https://www.youtube.com/@OneStarDao

At 8:00 PM on March 19, be sure to tune in to PS BigBig’s YouTube channel and witness whether the “BigBig Data Structure” can truly help AI “recognize its lineage” and gain soul-like reasoning abilities, all while adopting a zero-cost but not fully open-source model, heralding an “Honest Revolution” that may reshape the industry!

Media Contact
Company Name: PS BigBig
Contact Person: Organizer
Email: Send Email
City: Los Angeles
State: California
Country: United States
Website: onestardao.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: BigBig AGI 1.0 Demo Product Launch on March 19 is Set to Reveal the Secret of the AI “Soul”

Precision Fermentation Ingredients Market to Witness Rapid Growth: Industry Trends and Future Projections

“MarketsandMarkets™”
Precision Fermentation Ingredients Market by Ingredient (Whey & Casein Protein, Egg White, Collagen Protein, Heme Protein), Microbe (Yeast, Algae, Fungi, Bacteria) End User, Food & Beverage Application, and Region – Global Forecast to 2030

The global precision fermentation ingredients market is projected to grow from USD 2.8 billion in 2023 to USD 36.3 billion by 2030, reflecting a robust CAGR of 44.0% in value. This growth is driven by shifting consumer preferences toward veganism, rising protein consumption, and increased investments in innovation. Advances in genetic engineering have significantly enhanced the efficiency and sustainability of precision fermentation, enabling the reprogramming of microorganisms through synthetic biology to produce specialized food protein components cost-effectively.

Precision Fermentation Ingredients Market

Precision Fermentation Ingredients Market Growth Drivers

The growth of the Precision Fermentation Ingredients Market is driven by several key factors:

  • Rising Demand for Sustainable and Ethical Food Products: Consumers are increasingly concerned with sustainability, animal welfare, and environmental impacts. Precision fermentation offers a sustainable method to produce ingredients like proteins, flavors, and enzymes without relying on animal-based sources, driving demand in plant-based foods and other eco-friendly alternatives.
  • Advancements in Biotechnology and Fermentation Techniques: Continuous improvements in fermentation technology, such as more efficient microbial strains and enhanced fermentation processes, are reducing production costs and increasing the scalability of precision fermentation, making it an attractive option for ingredient production.
  • Growth of the Plant-based Food Industry: As plant-based food products gain popularity, there is a need for precision fermentation to create high-quality ingredients like proteins and enzymes that can be used to replicate the taste, texture, and nutritional profile of animal-derived products.
  • Rising Demand for Alternative Proteins: The global shift towards plant-based diets and the search for sustainable protein sources is propelling the demand for precision fermentation-derived proteins like those found in meat alternatives, dairy-free products, and other functional foods.
  • Regulatory Support for Biotech Innovations: Governments around the world are providing funding and favorable regulations for the development of innovative food production methods, including precision fermentation. This regulatory environment helps to reduce barriers to market entry and drives investment in the sector.
  • Consumer Preferences for Healthier and Clean Label Products: The growing preference for clean label foods with fewer artificial additives and more natural ingredients is benefiting precision fermentation, as it can provide ingredients that align with this trend.
  • Increased Investment from Major Corporations: Large food and beverage companies are investing heavily in precision fermentation to expand their product portfolios and gain a competitive edge in the rapidly growing market for alternative ingredients and food solutions.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30824914

Cosmetics & Others Segment to Lead with the Highest CAGR

The cosmetics & others segment is set for remarkable growth, projected to achieve the highest CAGR in the precision fermentation ingredients market. This surge aligns with the 2022 cosmetic trend, emphasizing the long-term benefits of fermented products. These formulations enhance skin absorption by breaking down substances, allowing vital nutrients to penetrate more effectively than non-fermented alternatives. A key player in this space, Geltor specializes in fermented ingredients for hair and skincare, further driving the segment’s expansion.

Meat & Seafood Segment to Dominate in Food & Beverage Applications

The meat & seafood segment is expected to witness the highest CAGR within the food & beverages precision fermentation ingredients market. This innovative approach leverages microorganisms like yeast, bacteria, fungi, and algae to produce plant-based proteins and fats, creating meat alternatives that replicate traditional textures, juiciness, and nutrition. The rising consumer preference for sustainable, health-conscious food choices is fueling the growth of this segment, reflecting the market’s shift towards environmentally friendly and nutritious options.

Request Sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=30824914

Heme Protein Segment to Experience Unprecedented Growth

Heme protein is projected to be the fastest-growing segment in the precision fermentation ingredients market, driven by advancements in microbial fermentation. This process primarily uses genetically modified yeast strains, such as Saccharomyces cerevisiae, to produce heme proteins in a sustainable and efficient manner, eliminating reliance on animal-derived sources. The United States remains a hub for research and development in this field, particularly in heme production for plant-based meat alternatives. Industry leaders like MycoTechnology Inc. and Impossible Foods are at the forefront of this innovation, showcasing the growing demand for fermentation-driven solutions across the alternative protein landscape.

The Asia Pacific region is dominate the precision fermentation ingredients market share.

This growth is driven by rapid urbanization and shifting consumer lifestyles, which have fueled demand for specialized products like alternative proteins and sustainable ingredients—key areas where precision fermentation excels. The region’s strong emphasis on technological advancements and innovation further supports the expansion of this market, creating a dynamic ecosystem for research and development. Additionally, consumers across Asia Pacific are increasingly open to adopting innovative products, demonstrating not just curiosity but active purchasing intent. Furthermore, rising investments and business expansions in the region are contributing to the market’s accelerated growth.

Top 10 Companies in the Precision Fermentation Ingredients Market

  • Geltor (US)
  • Perfect Day, Inc. (US)
  • The Every Co. (US)
  • Impossible Foods Inc. (US)
  • Motif FoodWorks, Inc. (US)
  • Imagindairy Ltd. (Israel)
  • Shiru, Inc. (US)
  • Formo (Germany)
  • Eden Brew (Australia)
  • Change Foods (US)

 

Geltor is a prominent bio-design firm that pioneers in advanced designer proteins. Integrating fermentation, biology, and protein optimization, Geltor produces sustainable and efficient alternative proteins with enhanced functionality. Their 100% animal-free and GMO-free ingredients are globally scalable and cultivated sustainably. Leveraging microbes, the company employs a fermentation process to create products using plant-based and renewable resources. In 2023, Geltor introduced Nucoll and Caviance, novel products catering to haircare and skincare needs. This evolution signifies a transformative approach to beauty and wellness, harnessing biotechnology’s potential for creating effective and eco-friendly alternatives.

Perfect Day, Inc. stands out as a prominent manufacturer of animal-free dairy products. It employs safe and established fermentation techniques to create animal-free whey protein using microflora. In contrast to conventional whey production methods, Perfect Day’s whey protein powder production achieves remarkable environmental efficiencies: a 99% reduction in water usage, a 97% decrease in greenhouse gas emissions, and approximately 60% lower non-renewable energy consumption. These figures are verified through ISO-compliant, third-party-reviewed life cycle assessments (LCAs). The company has established partnerships with multiple brands, expanding its presence in over 5,000 stores across the United States. Its market influence extends across North America and the Asia Pacific region as well.

Impossible Foods is engaged in providing plant-based fish, dairy, and meat products. The company’s product portfolio includes various plant-based products such as burgers, sausages, chicken nuggets, pork, and meatballs. Impossible Foods includes soy leghemoglobin manufactured through precision fermentation into its plant-based burger to provide the end product with the desired meat-like texture and taste. The company has its manufacturing facility located in Oakland, CA, US. Additionally, the company has partnered with one of the foremost food processing companies in the US, OSI Group, which provides extra manufacturing space to produce the popular Impossible Sausage and Impossible Burger. As a globally recognized entity, Impossible Foods serves customers across multiple countries, including the United States, Australia, Canada, Hong Kong, Macau, New Zealand, Singapore, the United Arab Emirates, and the United Kingdom.

Precision Fermentation Ingredients Industry News:

In May 2023, The EVERY Company and Alpha Foods officially entered into a Joint Development Agreement with the shared objective of bringing next-generation alt-meat products to the market. This collaboration aims to leverage EVERY’s trailblazing expertise in animal-free protein production and Alpha Foods’ renowned chef-crafted plant-based foods to accelerate advancements in taste and texture for non-animal products.

In March 2023, the partnership between The Hartman Group, Perfect Day, and Cargill enabled Perfect Day to gain valuable insights into consumer attitudes and preferences related to precision fermentation ingredients. This data has helped Perfect Day strengthen its position in the market, spearhead the Precision fermentation Alliance

In October 2022, Impossible Foods’ collaboration with Domino’s Australia, introducing Impossible™ Beef on their pizzas, strategically expands their market presence, boosts brand exposure, and appeals to environmentally conscious consumers.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/precision-fermentation-market-30824914.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Precision Fermentation Ingredients Market to Witness Rapid Growth: Industry Trends and Future Projections

Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Pulmonary Arterial Hypertension Pipeline Insight” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in Pulmonary Arterial Hypertension pipeline landscape. It covers the Pulmonary Arterial Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pulmonary Arterial Hypertension therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Pulmonary Arterial Hypertension Treatment Landscape. Click here to read more @ Pulmonary Arterial Hypertension Pipeline Outlook

Key Takeaways from the Pulmonary Arterial Hypertension Pipeline Report

  • In March 2025:- United Therapeutics conducted a study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right ventricular (RV) function and reverse RV remodeling in participants with pulmonary arterial hypertension (PAH).
  • In March 2025:- Actelion announced a study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.
  • In March 2025: Merck Sharp & Dohme LLC announced a study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to
  • DelveInsight’s Pulmonary Arterial Hypertension Pipeline analysis depicts a robust space with 55+ active players working to develop 55+ pipeline treatment therapies.
  • The leading Pulmonary Arterial Hypertension Companies such as Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, Gossamer Bio, Resverlogix, PhaseBio Pharmaceuticals, Pharmosa BioPharm, Complexa, Gmax Biopharm Australia, Mezzion, Radikal Therapeutics, Galectin Therapeutics, Altavant Sciences, Ribomic and others.
  • Promising Pulmonary Arterial Hypertension Therapies such as TPN171H, Tadalafil, Treprostinil Palmitil, Satralizumab (Genetical Recombination), PF-07868489, Sotatercept and others.

Discover groundbreaking developments in Pulmonary Arterial Hypertension therapies! Gain in-depth knowledge of key Pulmonary Arterial Hypertension clinical trials, emerging drugs, and market opportunities @ Pulmonary Arterial Hypertension Clinical Trials Assessment

Pulmonary Arterial Hypertension Emerging Drugs Profile

  • Sotatercept: Acceleron Pharma

Sotatercept is a first-in-class therapeutic fusion protein comprised of the extracellular domain of human activin receptor type IIA, fused to the Fc domain of human immunoglobulin G1 (IgG1). It provides balance of the growth-promoting activin growth differentiation factor pathway, and the growth-inhibiting BMP pathway by serving as a ligand trap for the TGF-β superfamily. The United States Food and Drug Administration (FDA) has granted Orphan Drug designation and Breakthrough Therapy designation to sotatercept for the treatment of PAH; the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to sotatercept for the treatment of PAH. Sotatercept is in Phase III clinical trial for the treatment of PAH.

  • LIQ861: Liquidia Technologies

LIQ861 is an investigational, inhaled dry powder formulation of treprostinil designed using the Company’s novel PRINT technology and engineered with the goal of enhancing deep-lung delivery of treprostinil in PAH patients by means of a convenient, palm-sized dry powder inhaler. Liquidia resubmits New Drug Application for LIQ861 under the 505(b)(2) regulatory pathway for the treatment of pulmonary arterial hypertension (PAH).

The Pulmonary Arterial Hypertension Pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Pulmonary Arterial Hypertension with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Pulmonary Arterial Hypertension Treatment.
  • Pulmonary Arterial Hypertension Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Pulmonary Arterial Hypertension Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Pulmonary Arterial Hypertension market

Stay informed about the Pulmonary Arterial Hypertension pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Pulmonary Arterial Hypertension Unmet Needs

Pulmonary Arterial Hypertension Companies

Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, Gossamer Bio, Resverlogix, PhaseBio Pharmaceuticals, Pharmosa BioPharm, Complexa, Gmax Biopharm Australia, Mezzion, Radikal Therapeutics, Galectin Therapeutics, Altavant Sciences, Ribomic and others.

Pulmonary Arterial Hypertension pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Parenteral
  • Intravitreal
  • Subretinal
  • Topical
  • Molecule Type

Pulmonary Arterial Hypertension Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

Transform your understanding of the Pulmonary Arterial Hypertension Pipeline! See the latest progress in drug development and clinical research @ Pulmonary Arterial Hypertension Market Drivers and Barriers, and Future Perspectives

Scope of the Pulmonary Arterial Hypertension Pipeline Report

  • Coverage- Global
  • Pulmonary Arterial Hypertension Companies- Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, Gossamer Bio, Resverlogix, PhaseBio Pharmaceuticals, Pharmosa BioPharm, Complexa, Gmax Biopharm Australia, Mezzion, Radikal Therapeutics, Galectin Therapeutics, Altavant Sciences, Ribomic and others.
  • Pulmonary Arterial Hypertension Therapies- TPN171H, Tadalafil, Treprostinil Palmitil, Satralizumab (Genetical Recombination), PF-07868489, Sotatercept and others.
  • Pulmonary Arterial Hypertension Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Pulmonary Arterial Hypertension Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Stay Ahead in Oncology Research–Access the Full Pulmonary Arterial Hypertension Pipeline Analysis Today! @ Pulmonary Arterial Hypertension Drugs and Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Pulmonary Arterial Hypertension: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Pulmonary Arterial Hypertension – DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Sotatercept: Acceleron Pharma
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. GB-002: Gossamer Bio
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. Apabetalone: Resverlogix
  15. Drug profiles in the detailed report…..
  16. Preclinical/Discovery Stage Products
  17. R107: Radikal Therapeutics
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Pulmonary Arterial Hypertension Key Companies
  21. Pulmonary Arterial Hypertension Key Products
  22. Pulmonary Arterial Hypertension- Unmet Needs
  23. Pulmonary Arterial Hypertension- Market Drivers and Barriers
  24. Pulmonary Arterial Hypertension- Future Perspectives and Conclusion
  25. Pulmonary Arterial Hypertension Analyst Views
  26. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/pulmonary-arterial-hypertension-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Pulmonary Arterial Hypertension Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Edible Oils Market Overview, Growth Drivers, Latest Trends, Opportunities, Key Segments, Top Companies, and Recent Developments

“MarketsandMarkets™”
Edible Oils Market by Type (Palm Oil, Soybean Oil, Sunflower Oil, Olive Oil, Rapeseed Oil), Packaging Type, Packaging Technology, Extraction Technology, Grade, Application, End Use, Distribution Channel and Region – Global Forecast to 2029

The global edible oils market is valued at USD 250.78 billion in 2024 and is expected to reach USD 306.92 billion by 2029, growing at a CAGR of 4.1% during the forecast period. Several key factors are driving this expansion, including rising consumer awareness of healthier cooking options and increasing disposable incomes.

Edible Oils Market

The growing preference for plant-based diets and sustainable food choices has fueled demand for nutrient-rich oils such as olive, sunflower, and coconut, known for their digestive benefits, essential fatty acids, and heart health advantages. Edible oils serve diverse culinary purposes, including frying, baking, dressings, and marinades.

Moreover, advancements in extraction technologies and product fortification with vitamins and antioxidants are opening new market opportunities. Rapid urbanization and shifting dietary habits in emerging markets across the Asia-Pacific and Africa are significantly contributing to the industry’s global growth.

Edible Oils Market Trends

Here are some key trends shaping the Edible Oils Market:

1. Growing Demand for Healthier Oils

· Consumers are shifting towards healthy oils like olive oil, avocado oil, and cold-pressed oils due to their nutritional benefits.

· Increased awareness of heart health, cholesterol control, and weight management is driving demand for oils rich in unsaturated fats, like canola and sunflower oil.

2. Rise of Functional and Fortified Edible Oils

· Fortification with omega-3, vitamin D, and antioxidants is gaining traction as consumers look for additional health benefits.

· Functional oils with anti-inflammatory and immune-boosting properties are entering the market.

3. Surging Popularity of Plant-Based and Sustainable Oils

· Sustainable and non-GMO oils (e.g., palm oil alternatives, algae oil) are in demand due to environmental concerns.

· Growth in plant-based diets is increasing the use of oils like coconut, flaxseed, and hemp oil in vegan food products.

4. Premiumization & Cold-Pressed Oils Boom

· Cold-pressed and extra virgin oils are gaining popularity due to their higher nutrient content and superior taste.

· Consumers are willing to pay a premium for organic and unrefined oils with minimal processing.

5. Expanding Industrial Applications

· The food industry is innovating with blended oils (e.g., olive and canola mix) for improved functionality.

· The cosmetics and personal care industry is also utilizing edible oils in skincare and haircare products.

Attractive Opportunities in the Edible Oils Market

· As urbanization increases, there is greater adoption of Western diets and convenience foods, boosting the consumption of edible oils in the region, especially in fast food and ready-to-eat meals.

· Collaborations and the introduction of new products are expected to present profitable prospects for industry participants in the next five years.

· Asia Pacific’s expanding population fuels the demand for edible oils, particularly in emerging markets like India and China, where consumer spending on processed foods is increasing.

· Government initiatives and subsidies in several Asia Pacific countries are supporting edible oil production and importation, ensuring affordable pricing and encouraging consumption among a broader demographic.

Soybean Oil Leads the Edible Oils Market by Type

Soybean oil holds the largest share in the edible oils market, driven by its extensive applications and nutritional benefits. Its widespread use in cooking, baking, and processed foods has fueled its growing demand. Rich in unsaturated fats, omega-3 fatty acids, and vitamin E, soybean oil supports heart health and boosts immunity, making it a preferred choice among health-conscious consumers.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198285285

Household Segment Witnesses Significant Growth in Edible Oils Market (2024-2029)

The household segment is experiencing strong growth in the edible oils market, fueled by rising population levels, increasing disposable incomes, and higher household consumption. As demand for edible oils in daily cooking surges, this segment continues to expand at a steady pace. According to the Government of India’s Ministry of Commerce & Industry (December 2023), domestic edible oilseed consumption is rising by approximately 10 LMT per year. This increase is primarily driven by a growing population and improved purchasing power, further supported by the expanding production capacities of edible oil manufacturers. With a robust domestic market and rising availability, the household segment is expected to maintain its upward trajectory alongside the global demand for edible oils.

Asia Pacific Poised for Rapid Growth in the Edible Oils Market (2024–2029)

The Asia-Pacific region is expected to witness the fastest growth in the edible oils market between 2024 and 2029, driven by a rising population, increasing disposable incomes, and a growing preference for healthier cooking oils. Key market players shaping this dynamic landscape include Wilmar International Ltd (Singapore), United Plantations Berhad (Malaysia), and the Adani Group (India).

A notable innovation in the region was introduced in June 2020 when United Plantations Berhad’s subsidiary, Unitate, launched NutroOlive—a unique blend of Extra Virgin Olive Oil and Red Palm Oil. This product is packed with carotenoids, monounsaturated fatty acids, antioxidants, and natural vitamins, making it an ideal choice for frying, baking, salad dressings, and general cooking. Additionally, NutroOlive has received sustainability certification from the Roundtable on Sustainable Palm Oil (RSPO), aligning with the increasing consumer demand for health-conscious and eco-friendly edible oils.

The surge in innovative and sustainable product offerings underscores the Asia-Pacific region’s position as a key driver of growth in the global edible oils market.

Top 10 Companies in the Edible Oils Market

· ADM (US)

· Bunge (US)

· Associated British Foods plc (UK)

· Wilmar International Ltd (Singapore)

· United Plantations Berhad (Malaysia)

· Sime Darby Berhad (Malaysia)

· BORGES AGRICULTURAL & INDUSTRIAL EDIBLE OILS, S.A.U. (Spain)

· Cargill Incorporated (US)

· GrainCorp (Australia)

· Hebany (UAE)

· ADM (US)

Edible Oils Industry News:

· In September 2024, ADM (US) acquired Vandamme Hungaria Kft (Hungary). This added a 700 metric ton/day non-GM multi-seed and corn germ processing facility. It will boost ADM’s capacity to fulfill the growing demand for non-GM edible oils in Europe while associated with its global sustainability efforts and increased commitment to food security throughout the world.

· In August 2024, Bunge (US) Launched Fiona Refined Sunflower Oil in Hyderabad, Telangana. It is further fortified with vitamins A, D, and E and boasts the novel VitoProtect formula, which increases vitamin transfer during cooking by as much as 50 percent compared with standard sunflower oils. This launch addressed increasing consumer demand for healthier oils to cook while maintaining nutritional value.

· In March 2023, Wilmar International Ltd. acquired the remaining 24% stake in Calofic Corporation (Vietnam), the leading producer and distributor of vegetable oils. This acquisition makes Calofic an indirect wholly owned subsidiary of Wilmar, enhancing its presence and market position in Vietnam. This shows that the company is committed to aggressively expanding its regional footholds.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/edible-oils-market-198285285.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Edible Oils Market Overview, Growth Drivers, Latest Trends, Opportunities, Key Segments, Top Companies, and Recent Developments

Acute Respiratory Distress Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Acute Respiratory Distress Syndrome Pipeline Insight” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the Acute Respiratory Distress Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Acute Respiratory Distress Syndrome therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore our latest breakthroughs in Acute Respiratory Distress Syndrome research. Learn more about our innovative pipeline today! @ Acute Respiratory Distress Syndrome Pipeline Outlook

Key Takeaways from the Acute Respiratory Distress Syndrome Pipeline Report

  • In March 2025:- PPD DEVELOPMENT LP conducted a study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Participants will be randomized to receive either a placebo or one of the active treatments.
  • In March 2025:- BioAegis Therapeutics Inc. announced a study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections. Potential subjects hospitalized with pneumonia or other infections are to be screened within 24 hours of diagnosis of ARDS.
  • DelveInsight’s Acute Respiratory Distress Syndrome Pipeline report depicts a robust space with 50+ active players working to develop 50+ pipeline therapies for Acute Respiratory Distress Syndrome treatment.
  • The leading Acute Respiratory Distress Syndrome Companies such as Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A, Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics Inc., Arch Biopartners, Ibudilast, and others.
  • Promising Acute Respiratory Distress Therapies such as STSA-1002, Rhu-pGSN, Reparixin 600mg, Centhaquine, MRG-001, TTI-0102, Dexamethasone, and others.

Stay informed about the cutting-edge advancements in Acute Respiratory Distress Syndrome treatments. Download for updates and be a part of the revolution in cancer care @ Acute Respiratory Distress Syndrome Clinical Trials Assessment

Acute Respiratory Distress Syndrome Emerging Drugs Profile

  • GEn 1124: GEn1E Lifesciences

GEn 1124 is an investigative small molecule drug being developed in collaboration with GEn1E Lifesciences and Biomedical Advanced Research and Development Authority (BARDA),part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to support the development of the company’s novel therapy for acute respiratory distress syndrome (ARDS), The drug candidate is mitogen activated protein kinase 14 inhibitors .Currently, the drug is in Phase II stage of its development for the treatment of acute respiratory distress syndrome.

  • ALT-100: Aqualung Therapeutics Corp.

ALT-100 is a “First in Man” immune-based monoclonal antibody (mAb) being developed by Aqualung Therapeutics Corp. ALT-100 antibody is a revolutionary, next generation antibody therapy. The humanized antibody has been developed and optimized by Fusion Antibodies’ revolutionary CDRx humanization and ADD develop ability platforms. This humanized monoclonal antibody will block systemic inflammation and will improve survival in the ARDS. ALT-100 inhibits eNAMPT binding to TLR4.Currently the drug is in Phase II stage of clinical trial for the treatment of acute distress respiratory syndrome.

  • STSA 1002: Staidson (Beijing) Biopharmaceuticals Co., Ltd

STSA 1002 is an investigative recombinant anti-human C5a IgG1 monoclonal antibody which acts by targeting complement C5a inhibitors C5a by specifically binding to anaphylatoxin C5a, C5a loses its ability to bind to receptors and blocks C5a-induced Biological functions, such as neutrophil chemotaxis, degranulation and oxygen respiratory burst, etc., while not affecting C5 cleavage and the formation of membrane attack complex (MAC), retaining the bacteriolytic and bactericidal functions of the complement system, thereby achieving the treatment of viruses, etc. Severe pneumonia, acute lung injury or acute respiratory distress syndrome caused by factors. It is administered through oral and subcutaneous route. Currently, the drug is in Phase I/II stage of its development for the treatment of acute respiratory distress syndrome.

  • Descartes 30: Cartesian Therapeutics

Descartes-30 is an off-the-shelf (allogeneic) MSC product engineered with Cartesian’s RNA ArmorySM cell therapy platform. Descartes-30 expresses a unique combination of DNases in patients and delivers a targeted treatment directly to the site of disease which eliminates neutrophil extracellular traps which are a key driver of inflammation and clotting in acute respiratory distress syndrome. The drug candidate relies on cell replacements mechanism of action. Currently the drug is in Phase I/II stage of clinical trial for the treatment of acute respiratory distress syndrome.

Learn more about Acute Respiratory Distress Syndrome Drugs opportunities in our groundbreaking metastatic prostate cancer research and development projects @ Acute Respiratory Distress Syndrome Unmet Needs

The Acute Respiratory Distress Syndrome Pipeline report provides insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Acute Respiratory Distress Syndrome with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Acute Respiratory Distress Syndrome Treatment.
  • Acute Respiratory Distress Syndrome Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Acute Respiratory Distress Syndrome Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Acute Respiratory Distress Syndrome market

Acute Respiratory Distress Syndrome Companies

Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A, Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics Inc., Arch Biopartners, Ibudilast, and others.

Acute Respiratory Distress Syndrome Pipeline Report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

  • Oral
  • Parenteral
  • Intravitreal
  • Subretinal
  • Topical

Acute Respiratory Distress Syndrome Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy

Discover the latest advancements in Acute Respiratory Distress Syndrome treatment by visiting our website. Stay informed about how we’re transforming the future of oncology @ Acute Respiratory Distress Syndrome Market Drivers and Barriers, and Future Perspectives

Scope of the Acute Respiratory Distress Syndrome Pipeline Report

  • Coverage- Global
  • Acute Respiratory Distress Syndrome Companies- Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A, Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics Inc., Arch Biopartners, Ibudilast, and others.
  • Acute Respiratory Distress Therapies- STSA-1002, Rhu-pGSN, Reparixin 600mg, Centhaquine, MRG-001, TTI-0102, Dexamethasone, and others.
  • Acute Respiratory Distress Syndrome Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Acute Respiratory Distress Syndrome Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

For a detailed overview of our latest research findings and future plans, read the full details of Acute Respiratory Distress Syndrome pipeline on our website @ Acute Respiratory Distress Syndrome Emerging Drugs and Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Acute Respiratory Distress Syndrome: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Acute Respiratory Distress Syndrome– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Drug name: Company name
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. GEn 1124: GEn1E Lifesciences
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I/II)
  14. STSA 1002: Staidson (Beijing) Biopharmaceuticals Co., Ltd
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug Name: Company Name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Acute Respiratory Distress Syndrome Key Companies
  21. Acute Respiratory Distress Syndrome Key Products
  22. Acute Respiratory Distress Syndrome- Unmet Needs
  23. Acute Respiratory Distress Syndrome- Market Drivers and Barriers
  24. Acute Respiratory Distress Syndrome- Future Perspectives and Conclusion
  25. Acute Respiratory Distress Syndrome Analyst Views
  26. Acute Respiratory Distress Syndrome Key Companies

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Acute Respiratory Distress Syndrome Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform

“CAR-T Cell Therapy”
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.

Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART™ technology platform, Protheragen provides investigators a wide range of disease models to ensure detailed and customized treatment methods for superior therapeutic outcomes.

With the development of immunology, scientists have come to recognize the potential of the immune system in recognizing and attacking cancer cells, especially the key role of T cells in anti-tumor immunity. Protheragen leverages this property of T cells to study and develop a variety of disease models to evaluate the effectiveness of immunotherapy and ensure optimal therapeutic outcomes through its innovative EndureCART™ technology.

In the field of tumor therapy, the emergence of CAR-T cell therapy provides a solution to the limitations of traditional treatment methods. CAR-T therapy works by genetically modifying one’s own T cells so that they can recognize and kill cancer cells more effectively. Therefore, this immunotherapy method has shown selectivity and high efficiency and has become a new direction for cancer treatment. Protheragen, a leading EndureCART™ technology provider, uses EndureCART™ to help researchers overcome the negative side effects that can occur in traditional oncology research and treatment approaches. This technology significantly improves the depth and breadth of cancer research.

In the research and application of CAR-T cell therapy, personalized therapy is an important direction in achieving the best efficacy. For different tumor characteristics and immune states, researchers need to develop customized treatment options to meet specific needs. Protheragen’s customized CAR-T cell therapy services are designed to provide research and development programs tailored to specific tumor characteristics and health conditions. This personalized approach helps to improve the pertinence and validity of the research.

In addition, the production process of CAR-T cells is complex and time-consuming, its therapeutic effect may be affected by a variety of factors, thus affecting the results of the study. To address this challenge, Protheragen is leveraging its extensive experience in hematologic tumor immunotherapy and its advanced EndureCART™ technology to enhance the efficacy and durability of CAR-T therapy and provide a more effective experimental basis for related studies.

Protheragen is committed to providing a one-stop CAR-T cell therapy development platform for researchers to choose the most suitable solution among many services. To ensure a quality service experience for customers, Protheragen has a professional consulting team ready to answer any questions and provide the necessary support and guidance to help them complete their research tasks. “Our goal is to provide more efficient solutions for our customers’ research projects through professional services and reliable technical support.” said the team at Protheragen.

Protheragen draws on its extensive expertise and advanced EndureCART™ technology to provide a diverse range of disease models for CAR-T cell therapy. At the same time, Protheragen provides customized CAR-T analysis and therapy services based on the needs of the investigators. This flexibility guarantees the validity and accuracy of the study results and promotes the development of CAR-T cell therapy research.

About Protheragen

As a provider of CAR-T research solutions, Protheragen offers a wide range of disease models and customized services for CAR-T cell therapy development using EndureCART™ technology platforms and comprehensive research services.

Media Contact
Company Name: Protheragen
Contact Person: Leona Reilly
Email: Send Email
Country: United States
Website: https://www.protheragen.us/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Protheragen Unveils Revolutionary EndureCAR-T™ Cell Therapy Platform